Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Tianhang, Zhai"'
Autor:
Chao Wang, Yi Luo, Tianhang Zhai, Weifeng Huang, Shuang Dai, Shaogang Peng, Andy Tsun, Xiaoniu Miao, Liandi Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5df9ef5fbac9433badca5ee537f90762
Autor:
Bin Li, Tao Wang, Yuhua Huang, Yifeng Xu, Chao Wang, Tianhang Zhai, Weifeng Huang, Zhijun Yuan, Shuang Dai, Shaogang Peng, Tuling Pang, Wenchao Jiang, Yuefeng Zou, Yingda Xu, Joanne Sun, Xinjiang Gong, Andy Tsun, Xiaoniu Miao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3dbbec51dffb4bd1af30fea60b05704e
Autor:
Jun Shi, Rongfen Huo, Ningli Li, Haichuan Li, Tianhang Zhai, Huidan Li, Baihua Shen, Jing Ye, Ruojin Fu, Wen Di
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Recent studies have found that inflammatory response is involved in the pathogenesis of ovarian cancer. Advanced ovarian cancer is often presented with ascites that is rich in cytokines, inflammatory factors or cancer cells. There
Externí odkaz:
https://doaj.org/article/be02a23470bb44a5ad802767399f8acc
Autor:
Bin Li, Jinping Zhang, Tao Wang, Yuhua Huang, Yifeng Xu, Chao Wang, Tianhang Zhai, Weifeng Huang, Zhijun Yuan, Shuang Dai, Shaogang Peng, Tuling Pang, Wenchao Jiang, Yuefeng Zou, Yingda Xu, Joanne Sun, Xinjiang Gong, Andy Tsun, Xiaoniu Miao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background The discovery of checkpoint inhibitors towards cytotoxic T-lymphocyte protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) has been revolutionary for the treatment of cancers. These therapies have only offered an average of 20%–
Externí odkaz:
https://doaj.org/article/3e340593657c4bfda3b3c3eb21844f31
Autor:
Jie Zhang, Jie Shu, Hanxiao Sun, Tianhang Zhai, Huidan Li, Haichuan Li, Yue Sun, Rongfen Huo, Baihua Shen, Huiming Sheng
Publikováno v:
The Journal of Dermatology. 50:337-348
Autor:
Tianhang Zhai, Yue Sun, Huidan Li, Jie Zhang, Rongfen Huo, Haichuan Li, Baihua Shen, Ningli Li
Publikováno v:
Journal of Pharmacological Sciences, Vol 130, Iss 3, Pp 143-150 (2016)
It has been widely accepted that macrophages are divided into M1 “pro-inflammatory” macrophages and M2 “anti-inflammatory” macrophages and an uncontrolled macrophage polarization plays an important role in the pathogenesis of different diseas
Externí odkaz:
https://doaj.org/article/72fc2614dda7436c919c4a21e448f01b
Autor:
Jie Zhang, Huidan Li, Rongfen Huo, Tianhang Zhai, Haichuan Li, Yue Sun, Baihua Shen, Ningli Li
Publikováno v:
Journal of Pharmacological Sciences, Vol 128, Iss 1, Pp 8-16 (2015)
B cells are important in the development of autoimmune disorders through mechanisms involving dysregulated polyclonal B-cell activation, production of pathogenic antibodies, and targeting which reduces inflammation and tissue damage effectively but o
Externí odkaz:
https://doaj.org/article/c6e25cf5c7f340e1852192e5ac83cb04
Autor:
Shuang Dai, Weifeng Huang, Longjun Yan, Shaogang Peng, Shihui Zhou, Zhijun Yuan, Chao Wang, Chuan-Chu Chou, Andy Tsun, Tianhang Zhai
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Jie, Zhang, Jie, Shu, Hanxiao, Sun, Tianhang, Zhai, Huidan, Li, Haichuan, Li, Yue, Sun, Rongfen, Huo, Baihua, Shen, Huiming, Sheng
Publikováno v:
The Journal of dermatologyREFERENCES.
Psoriasis is a chronic skin disorder characterized by epidermal keratinocyte hyperproliferation and inflammatory infiltration. CCN1 (also termed CYR61 or cysteine-rich angiogenic inducer 61) is an extracellular matrix-associated protein that is invol
Autor:
Tao Wang, Tuling Pang, Xinjiang Gong, Yuhua Huang, Yuefeng Zou, Tianhang Zhai, Yingda Xu, Xiaoniu Miao, Joanne Sun, Shaogang Peng, Weifeng Huang, Bin Li, Yifeng Xu, Zhijun Yuan, Andy Tsun, Chao Wang, Shuang Dai, Wenchao Jiang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCheckpoint inhibitors towards cytotoxic T-lymphocyte protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have paved the way for a new frontier of anti-cancer therapies that modulate our pre-existing immune system to fight against